🇺🇸 Xolair injections in United States

12 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 12

Most-reported reactions

1. Dyspnoea — 2 reports (16.67%)
2. Malaise — 2 reports (16.67%)
3. Adverse Event — 1 report (8.33%)
4. Cough — 1 report (8.33%)
5. Diarrhoea — 1 report (8.33%)
6. Drug Ineffective — 1 report (8.33%)
7. Gastric Disorder — 1 report (8.33%)
8. Gastrooesophageal Reflux Disease — 1 report (8.33%)
9. Hiatus Hernia — 1 report (8.33%)
10. Insomnia — 1 report (8.33%)

Source database →

Frequently asked questions

Is Xolair injections approved in United States?

Xolair injections does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Xolair injections in United States?

University of California, Los Angeles is the originator. The local marketing authorisation holder may differ — check the official source linked above.